Alberto Martini , MD

Alberto Martini is an Assistant Professor and the Director of Research in the Department of Urology.

He is extensively trained in robotic and laparoscopic surgery, having been mentored by pioneers in minimally invasive surgery. His professional experience spans the USA (New York City and Houston), Europe (Florence, Milan, Dresden, Prague, and Toulouse), and Australia (Melbourne). He also received specialized training in gene therapy for bladder cancer under Dr. Dinney, a gene therapy pioneer for bladder cancer, at MD Anderson Cancer Center.
 
Dr. Martini is passionate about advancing research and utilizing innovative statistical methods to enhance healthcare approaches and patient outcomes. He has authored over 170 research articles and earned national and international recognition for his work. Notably, he holds a patent for the integration of 3D models during robotic prostatectomy, reflecting his commitment to improving surgical precision and patient care.
 
His clinical and research focus is on urological oncology, specifically prostate, bladder, and kidney cancer.

Dr. Martini actively contributes to several international working groups, including the European Association of Urology (EAU) – Young Academic Urologists group on Prostate Cancer. He is also an associate member of the scientific working group of the Robotic Urology Section of the EAU and the EAU Guidelines on muscle-invasive and metastatic bladder cancer.
 
Dr. Martini completed a fellowship in urologic oncology at MD Anderson Cancer Center in Houston, TX. Before joining MD Anderson, he was a fellow in minimally invasive urology at Clinic La Croix du Sud in Toulouse, France, and a Research Consultant at the University Cancer Institute of Toulouse "Oncopole."
 
His residency in Urology was completed at San Raffaele Hospital in Milan, Italy, where he also spent two years at Mount Sinai Hospital in New York City, gaining expertise in robotic surgery under the guidance of leading experts.
 
Dr. Martini earned his medical degree from the University of Florence, during which he completed semesters at Charles University in Prague and Monash University in Melbourne. Additionally, he undertook a four-month internship at the Department of Urology, Carl Gustav Carus University, Dresden, Germany.
 
Dr. Martini speaks English, Italian, French and German.

Fellowship: The University of Texas, MD Anderson Cancer Center Houston, TX, (Urologic Oncology)

Fellowship: La Croix du Sud Hospital Toulouse, France, (Minimally Invasive Urology)

Fellowship: The Mount Sinai Hospital New York City, (Robotic Prostatectomy)

Residency: San Raffaele Hospital Milan, Italy, (General Urology)

Medical Degree: University of Florence Florence, Italy, (MD)

Blood in urine (Hematuria)

Prostate Cancer

Urologic Cancer

Bladder Cancer

Kidney Cancer

Urology

Urology

Dr. Martini's clinical and research focus is on urological oncology, specifically prostate cancer, bladder cancer, and kidney cancer.

Peer Reviewed Publications

Ben-David R.; Pellegrino F.; Alerasool P.; Tillu N.; Lavallee E.; Attalla K.; Waingankar N.; John S.P.; Mehrazin R.; Moschini M.; Martini A.; Edeling S.; Briganti A.; Montorsi F.; Wiklund P. (12-01-2024. ) Robotic-assisted radical cystectomy with cutaneous ureterostomies: a contemporary multicenter analys.World Journal of Urology, , 42 (1 ) , More Information

d’Agate D.; Martini A.; Lesourd M.; Tollon C.; Loison G.; Almeras C.; Pradère B.; Salin A.; Beauval J.B.; Ploussard G. (12-01-2024. ) Patient experience and satisfaction after same-day discharge radical prostatectomy using a personali.World Journal of Urology, , 42 (1 ) , More Information

Zattoni F.; Fasulo V.; Kasivisvanathan V.; Kesch C.; Marra G.; Martini A.; Falagario U.; Soeterik T.; van den Bergh R.; Rajwa P.; Gandaglia G. (08-01-2024. ) Enhancing Prostate Cancer Detection Accuracy in Magnetic Resonance Imaging–targeted Prostate Biopsy:.European Urology Open Science, , 66 ,16-25 More Information

Pellegrino F.; Falagario U.G.; Knipper S.; Martini A.; Akre O.; Egevad L.; Aly M.; Moschovas M.C.; Bravi C.A.; Tran J.; Heiniger Y.; von Kempis A.; Schaffar R.; Carrieri G.; Briganti A.; Montorsi F.; Rochat C.H.; Mottrie A.; Ahlering T.E.; John H.; Patel V.; Graefen M.; Wiklund P. (08-01-2024. ) Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Rad.European urology oncology, , 7 (4 ) ,888-896 More Information

Falagario U.G.; Knipper S.; Pellegrino F.; Martini A.; Akre O.; Egevad L.; Grönberg H.; Moschovas M.C.; Bravi C.A.; Tran J.; Heiniger Y.; von Kempis A.; Schaffar R.; Carrieri G.; Rochat C.H.; Mottrie A.; Ahlering T.E.; John H.; Patel V.; Graefen M.; Wiklund P. (08-01-2024. ) Prostate Cancer-specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Year.European urology oncology, , 7 (4 ) ,705-712 More Information

Bonavina G.; Busnelli A.; Acerboni S.; Martini A.; Candiani M.; Bulfoni A. (06-01-2024. ) Surgical repair of post-cesarean vesicouterine fistula: A systematic review and a plea for preventio.International Journal of Gynecology and Obstetrics, , 165 (3 ) ,894-915 More Information

Contieri R.; Tan W.S.; Grajales V.; Hensley P.J.; Martini A.; Bree K.; Myers A.; Nogueras-Gonzalez G.; Navai N.; Dinney C.P.; Guo C.; Kamat A.M. (06-01-2024. ) Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer i.BJU International, , 133 (6 ) ,733-741 More Information

Alfred Witjes J.; Bruins H.M.; Carrión A.; Cathomas R.; Compérat E.; Efstathiou J.A.; Fietkau R.; Gakis G.; Lorch A.; Martini A.; Mertens L.S.; Meijer R.P.; Milowsky M.I.; Neuzillet Y.; Panebiaco V.; Redlef J.; Rink M.; Rouanne M.; Thalmann G.N.; Sæbjørnsen S.; Veskimäe E.; Mariappan P.; van der Heijden A.G. (06-01-2024. ) Corrigendum to “European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder.European Urology, , 85 (6 ) ,e180 More Information

Pellegrino F.; Martini A.; Falagario U.G.; Rautiola J.; Russo A.; Mertens L.S.; Di Gianfrancesco L.; Bravi C.A.; Vollemaere J.; Abdeen M.; Moschini M.; Mendrek M.; Kjøbli E.; Buse S.; Wijburg C.; Touzani A.; Ploussard G.; Antonelli A.; Schwenk L.; Ebbing J.; Vasdev N.; Froelicher G.; John H.; Canda A.E.; Balbay M.D.; Stoll M.; Edeling S.; Berquin C.; Van Praet C.; Leyh-Bannurah S.R.; Siemer S.; Stoeckle M.; Mottrie A.; D'Hondt F.; Crestani A.; Porreca A.; Briganti A.; Montorsi F.; van der Poel H.; Dacaestecker K.; Gaston R.; Hosseini A.; Wiklund N.P. (06-01-2024. ) How can we reduce morbidity after robot-assisted radical cystectomy with intracorporeal neobladder? .BJU International, , 133 (6 ) ,673-677 More Information

Grajales V.; Martini A.; Shore N.D. (05-01-2024. ) Complications of immuno-oncology care: what urologist should know.BJU International, , 133 (5 ) ,524-531 More Information

Falagario U.G.; Martini A.; Pellegrino F.; Carrieri G.; Manon M.; Lantz A.; Wiklund P. (02-01-2024. ) Re: Derya Tilki, Ming-Hui Chen, Jing Wu, et al. Prostate-specific Antigen Level at the Time of Salva.European urology oncology, , 7 (1 ) ,167-168 More Information

Basile G.; Gallioli A.; Martini A.; Verri P.; Robalino J.; Dieguez L.; Gavrilov P.; Territo A.; Uleri A.; Gaya J.M.; Algaba F.; Palou J.; Breda A. (02-01-2024. ) Oncologic surveillance intensity after endoscopic treatment of upper tract urothelial carcinoma.Minerva Urology and Nephrology, , 76 (1 ) ,88-96 More Information

Robesti D.; Nocera L.; Belladelli F.; Schultz J.G.; Fallara G.; Marandino L.; Raggi D.; Montorsi F.; Msaouel P.; Necchi A.; Martini A. (02-01-2024. ) The immune-related adverse events paradox in locally advanced or metastatic urothelial cancer after .BJU International, , 133 (2 ) ,158-168 More Information

Contieri R.; Grajales V.; Tan W.S.; Martini A.; Sood A.; Hensley P.; Bree K.; Lobo N.; Nogueras-Gonzalez G.M.; Guo C.C.; Navai N.; Dinney C.P.; Kamat A.M. (01-01-2024. ) Impact of age >70 years on oncological outcomes in patients with non-muscle-invasive bladder .BJU International, , 133 (1 ) ,63-70 More Information

Alfred Witjes J.; Max Bruins H.; Carrión A.; Cathomas R.; Compérat E.; Efstathiou J.A.; Fietkau R.; Gakis G.; Lorch A.; Martini A.; Mertens L.S.; Meijer R.P.; Milowsky M.I.; Neuzillet Y.; Panebianco V.; Redlef J.; Rink M.; Rouanne M.; Thalmann G.N.; Sæbjørnsen S.; Veskimäe E.; van der Heijden A.G. (01-01-2024. ) European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary.European Urology, , 85 (1 ) ,17-31 More Information

Martini A.; Wever L.; Soeterik T.F.W.; Rakauskas A.; Fankhauser C.D.; Grogg J.B.; Checcucci E.; Amparore D.; Haiquel L.; Rodriguez-sanchez L.; Ploussard G.; Qiang P.; Affentranger A.; Marquis A.; Marra G.; Ettala O.; Zattoni F.; Falagario U.G.; De Angelis M.; Kesch C.; Apfelbeck M.; Al-Hammouri T.; Kretschmer A.; Kasivisvanathan V.; Preisser F.; Lefebvre E.; Olivier J.; Radtke J.P.; Carrieri G.; Moro F.D.; Boström P.; Jambor I.; Gontero P.; Chiu P.K.; John H.; Macek P.; Porpiglia F.; Hermanns T.; van den Bergh R.C.N.; van Basten J.P.A.; Gandaglia G.; Valerio M. (01-01-2024. ) An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted bi.Prostate Cancer and Prostatic Diseases, , More Information

Rodriguez-Sanchez L.; Martini A.; Martini A.; Zhuang J.; Guo H.; Rajwa P.; Rajwa P.; Mandoorah Q.; Haiquel L.; Shariat S.F.; Gandaglia G.; Valerio M.; Marra G. (01-01-2024. ) External validation of an algorithm to personalize nerve sparing approaches during robot-assisted ra.Prostate Cancer and Prostatic Diseases, , More Information

Contieri R.; Martini A.; Mertens L.S.; Giannatempo P.; Hurle R.; Witjes J.A.; Ribal M.J.; van Rhijn B.W.G.; Malavaud B. (01-01-2024. ) The Financial Burden of Guideline-recommended Cancer Medications for Metastatic Urothelial Carcinoma.European Urology Focus, , More Information

Windisch O.; Diana M.; Tilki D.; Marra G.; Martini A.; Valerio M. (01-01-2024. ) Intraoperative technologies to assess margin status during radical prostatectomy – a narrative revie.Prostate Cancer and Prostatic Diseases, , More Information

Touzani A.; D'Agate D.; Kesch C.; Calleris G.; Buhas B.; Abou-Zahr R.; Rahota R.G.; Ouzzane A.; Pradère B.; Tollon C.; Martini A.; Ploussard G. (01-01-2024. ) One-year outcomes of same-day-discharge robot-assisted radical prostatectomy.BJU International, , More Information

Martini A.; Ploussard G. (12-01-2023. ) Reply to: Fact, overdiagnosis cannot be evaluated by comparing histological grading of prostate biop.Prostate Cancer and Prostatic Diseases, , 26 (4 ) ,802-803 More Information

Martini A.; Touzani A.; Mazzone E.; Roumiguié M.; Marra G.; Valerio M.; Beauval J.B.; Campi R.; Minervini A.; van den Berg R.C.N.; van den Berg R.C.N.; Soeterik T.F.W.; Zhuang J.; Guo H.; Gontero P.; Montorsi F.; Briganti A.; Gandaglia G.; Ploussard G. (12-01-2023. ) Correction to: Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: fac.Prostate Cancer and Prostatic Diseases, , 26 (4 ) ,806 More Information

Martini A.; Falagario U.G.; Russo A.; Mertens L.S.; Di Gianfrancesco L.; Bravi C.A.; Vollemaere J.; Abdeen M.; Mendrek M.; Kjøbli E.; Buse S.; Wijburg C.; Touzani A.; Ploussard G.; Antonelli A.; Schwenk L.; Ebbing J.; Vasdev N.; Froelicher G.; John H.; Canda A.E.; Balbay M.D.; Stoll M.; Edeling S.; Witt J.H.; Leyh-Bannurah S.R.; Siemer S.; Stoeckle M.; Mottrie A.; D'Hondt F.; Crestani A.; Porreca A.; van der Poel H.; Decaestecker K.; Gaston R.; Peter Wiklund N.; Hosseini A. (11-01-2023. ) Robot-assisted Radical Cystectomy with Orthotopic Neobladder Reconstruction: Techniques and Function.European Urology, , 84 (5 ) ,484-490 More Information

Treacy P.J.; Falagario U.G.; Magniez F.; Ratnani P.; Wajswol E.; Martini A.; Jambor I.; Wiklund P.; Bentellis I.; Barthe F.; Kyprianou N.; Durand M.; Steffens D.; Karunaratne S.; Leslie S.; Thanigasalam R.; Tewari A. (10-01-2023. ) Decipher Score predicts prostate specific antigen persistence after prostatectomy.Minerva Urology and Nephrology, , 75 (5 ) ,583-590 More Information

Martini A.; Fallara G.; Ploussard G.; Malavaud B. (10-01-2023. ) Combination therapy with olaparib and abiraterone acetate for metastatic castration-resistant prosta.The Lancet Oncology, , 24 (10 ) ,1056-1057 More Information

Falagario U.G.; Abbadi A.; Remmers S.; Björnebo L.; Bogdanovic D.; Martini A.; Valdman A.; Carrieri G.; Menon M.; Akre O.; Eklund M.; Nordström T.; Grönberg H.; Lantz A.; Wiklund P. (09-05-2023. ) Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy.JAMA network open, , 6 (9 ) ,e2332900 More Information

Venkatesh N.; Martini A.; McQuade J.L.; Msaouel P.; Hahn A.W. (09-01-2023. ) Obesity and renal cell carcinoma: Biological mechanisms and perspectives.Seminars in Cancer Biology, , 94 ,21-33 More Information

Halme A.L.E.; McAlpine K.; Martini A. (09-01-2023. ) Fixed-effect Versus Random-effects Models for Meta-analyses: Random-effects Models.European Urology Focus, , 9 (5 ) ,693-694 More Information

Martini A.; Touzani A.; Ploussard G. (09-01-2023. ) Lower Detrusor Apron–sparing Robot-assisted Radical Cystectomy and Intracorporeal Neobladder Reconst.European Urology Focus, , 9 (5 ) ,760-764 More Information

Musso G.; Fallara G.; Rosiello G.; Martini A.; Re C.; Cei F.; Basile G.; Cignoli D.; Colandrea G.; Rowe I.; Larcher A.; Salonia A.; Montorsi F.; Capitanio U. (08-01-2023. ) Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell C.Clinical Genitourinary Cancer, , 21 (4 ) ,e279-e285.e1 More Information

Baboudjian M.; Gondran-Tellier B.; Touzani A.; Martini A.; Diamand R.; Roche J.B.; Lacetera V.; Beauval J.B.; Roumeguère T.; Simone G.; Benamran D.; Fourcade A.; Fiard G.; van den Bergh R.C.N.; Peltier A.; Ploussard G. (08-01-2023. ) Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatec.European urology oncology, , 6 (4 ) ,406-413 More Information

Martini A.; Wever L.; Soeterik T.F.W.; Rakauskas A.; Fankhauser C.D.; Grogg J.B.; Checcucci E.; Amparore D.; Haiquel L.; Rodriguez-Sanchez L.; Ploussard G.; Qiang P.; Affentranger A.; Marquis A.; Marra G.; Ettala O.; Zattoni F.; Falagario U.G.; De Angelis M.; Kesch C.; Apfelbeck M.; Al-Hammouri T.; Kretschmer A.; Kasivisvanathan V.; Preisser F.; Lefebvre E.; Olivier J.; Radtke J.P.; Briganti A.; Montorsi F.; Carrieri G.; Moro F.D.; Boström P.; Jambor I.; Gontero P.; Chiu P.K.; John H.; MacEk P.; Porpiglia F.; Hermanns T.; Van Den Bergh R.C.N.; Van Basten J.P.A.; Gandaglia G.; Valerio M. (07-01-2023. ) Reply by Authors.Journal of Urology, , 210 (1 ) ,127 More Information

Martini A.; Wever L.; Soeterik T.F.W.; Rakauskas A.; Fankhauser C.D.; Grogg J.B.; Checcucci E.; Amparore D.; Haiquel L.; Rodriguez-Sanchez L.; Ploussard G.; Qiang P.; Affentranger A.; Marquis A.; Marra G.; Ettala O.; Zattoni F.; Falagario U.G.; De Angelis M.; Kesch C.; Apfelbeck M.; Al-Hammouri T.; Kretschmer A.; Kasivisvanathan V.; Preisser F.; Lefebvre E.; Olivier J.; Radtke J.P.; Briganti A.; Montorsi F.; Carrieri G.; Moro F.D.; Boström P.; Jambor I.; Gontero P.; Chiu P.K.; John H.; MacEk P.; Porpiglia F.; Hermanns T.; Van Den Bergh R.C.N.; Van Basten J.P.A.; Gandaglia G.; Valerio M. (07-01-2023. ) Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic.Journal of Urology, , 210 (1 ) ,117-126 More Information

Zattoni F.; Marra G.; Martini A.; Kasivisvanathan V.; Grummet J.; Harkin T.; Ploussard G.; Olivier J.; Chiu P.K.; Valerio M.; Marquis A.; Gontero P.; Guo H.; Zhuang J.; Frydenberg M.; Moon D.; Morlacco A.; Kretschmer A.; Barletta F.; Heidegger I.; Tilki D.; van den Bergh R.; Dal Moro F.; Briganti A.; Montorsi F.; Novara G.; Gandaglia G. (07-01-2023. ) Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsy on.European Urology Focus, , 9 (4 ) ,621-628 More Information

Bravi C.A.; Piazza P.; Mazzone E.; Dell’Oglio P.; Rosiello G.; Martini A.; Stabile A.; Moschini M.; Amato M.; Sarchi L.; Peraire M.; Farinha R.; Scarcella S.; Puliatti S.; Knipper S.; Berquin C.; Develtere D.; Sinatti C.; Van Puyvelde H.; De Groote R.; De Naeyer G.; D’Hondt F.; Schatteman P.; Briganti A.; Montorsi F.; Mottrie A. (06-01-2023. ) Long-term oncologic outcomes of robot-assisted radical cystectomy: update series from a high-volume .Journal of Robotic Surgery, , 17 (3 ) ,1143-1150 More Information

Sacco M.; Gandaglia G.; Aas K.; Ceci F.; Chiu P.; Fankhauser C.D.; Fournier G.; Heiddeger I.; Kasivisvanathan V.; Kesch C.; Maggi M.; Martini A.; Olivier J.; Ploussard G.; Preisser F.; Puche-Sanz I.; Rajwa P.; Soeterik T.; Thibault C.; Valerio M.; van den Bergh R.C.N.; Zattoni F.; Rivas J.G.; Moschini M.; Gillessen S.; Bossi A.; Gontero P.; Marra G. (06-01-2023. ) The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Er.Clinical Genitourinary Cancer, , 21 (3 ) ,416.e1-416.e10 More Information

Fallara G.; Robesti D.; Raggi D.; Montorsi F.; Necchi A.; Cooperberg M.R.; Malavaud B.; Ploussard G.; Martini A. (06-01-2023. ) Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castratio.European Urology Open Science, , 52 ,40-43 More Information

Treacy P.J.; Martini A.; Falagario U.G.; Ratnani P.; Wajswol E.; Beksac A.T.; Wiklund P.; Nair S.; Kyprianou N.; Durand M.; Tewari A.K. (04-01-2023. ) Association between Expression of Connective Tissue Genes and Prostate Cancer Growth and Progression.International Journal of Molecular Sciences, , 24 (8 ) , More Information

Bravi C.A.; Mazzone E.; Dell'Oglio P.; Covas Moschovas M.; Martini A.; Rosiello G.; Piazza P.; Mottaran A.; Paciotti M.; Sarchi L.; Puliatti S.; Knipper S.; de Groote R.; Schiavina R.; Rocco B.; Galfano A.; Briganti A.; Montorsi F.; Patel V.; Mottrie A. (04-01-2023. ) A nomogram to predict pathologic T2 stage in candidates to robot-assisted radical prostatectomy with.Minerva Urology and Nephrology, , 75 (2 ) ,231-234 More Information

Pellegrino F.; Tin A.L.; Martini A.; Vertosick E.A.; Porwal S.P.; Stabile A.; Gandaglia G.; Eastham J.A.; Briganti A.; Montorsi F.; Vickers A.J. (03-01-2023. ) Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients w.European Urology Focus, , 9 (2 ) ,291-297 More Information

Rosiello G.; Larcher A.; Fallara G.; Cignoli D.; Re C.; Martini A.; Tian Z.; Karakiewicz P.I.; Mottrie A.; Boarin M.; Villa G.; Trevisani F.; Marandino L.; Raggi D.; Necchi A.; Bertini R.; Salonia A.; Briganti A.; Montorsi F.; Capitanio U. (03-01-2023. ) A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patie.Urologic Oncology: Seminars and Original Investigations, , 41 (3 ) ,149.e17-149.e25 More Information

Martini A.; Valerio M. (02-01-2023. ) An Algorithm to Personalize Nerve Sparing in Men With Unilateral High-risk Prostate Cancer. Reply.Journal of Urology, , 209 (2 ) ,325 More Information

Baboudjian M.; Touzani A.; Martini A.; Diamand R.; Roche J.B.; Lacetera V.; Beauval J.B.; Gondran-Tellier B.; Roumeguère T.; Simone G.; Windisch O.; Benamran D.; Fourcade A.; Fiard G.; van Den Bergh R.C.; Peltier A.; Ploussard G. (02-01-2023. ) Oncological outcomes of radical prostatectomy in very high-risk patients according to STAMPEDE crite.Minerva Urology and Nephrology, , 75 (1 ) ,124-126 More Information

Tholomier C.; Martini A.; Mokkapati S.; Dinney C.P. (01-01-2023. ) The current status of gene therapy in bladder cancer.Expert Review of Anticancer Therapy, , 23 (5 ) ,531-543 More Information

Martini A.; Tholomier C.; Mokkapati S.; Dinney C.P.N. (01-01-2023. ) Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval.Frontiers in Immunology, , 14 , More Information

Saouli A.; Touzani A.; Martini A.; Beauval J.B.; Dergamoun H.; Ziouziou I.; Deffar N.; Ploussard G.; Ouzzane A. (01-01-2023. ) Is there a role for radical prostatectomy in the management of oligometastatic prostate cancer? A sy.Prostate Cancer and Prostatic Diseases, , More Information

Falagario U.G.; Chakravarty D.; Martini A.; Shahait M.; El-Fahmawi A.; Jambor I.; Lantz A.; Grannas D.; Ratnani P.; Parekh S.; Lundon D.; Haines K.; Cormio L.; Carrieri G.; Kyprianou N.; Kattan M.W.; Klein E.A.; Wiklund P.; Lee D.I.; Tewari A. (01-01-2023. ) When to order genomic tests: development and external validation of a model to predict high-risk pro.World Journal of Urology, , 41 (1 ) ,85-92 More Information

Bravi C.A.; Gandaglia G.; Mazzone E.; Fossati N.; Gallina A.; Stabile A.; Scuderi S.; Barletta F.; Nocera L.; Rosiello G.; Martini A.; Pellegrino F.; Cucchiara V.; Dehò F.; Capitanio U.; Scattoni V.; Salonia A.; Briganti A.; Montorsi F. (01-01-2023. ) Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted R.European Urology Focus, , 9 (1 ) ,83-88 More Information

Martini A.; Touzani A.; Beauval J.B.; Ruffion A.; Olivier J.; Gasmi A.; Dariane C.; Thoulouzan M.; Barret E.; Brureau L.; Créhange G.; Fiard G.; Gauthé M.; Renard-Penna R.; Roubaud G.; Sargos P.; Roumiguié M.; Timsit M.O.; Mathieu R.; Villers A.; Rouprêt M.; Fromont G.; Ploussard G. (12-01-2022. ) Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimens.World Journal of Urology, , 40 (12 ) ,2931-2937 More Information

Fallara G.; Fankhauser C.D.; Martini A. (12-01-2022. ) Comment on: “Improving the stratification of intermediate risk prostate cancer”.Minerva Urology and Nephrology, , 74 (6 ) ,819-821 More Information

Maggi M.; Gandaglia G.; Rajwa P.; Martini A.; Marra G. (12-01-2022. ) The current evidence on prognostic factors in metastatic castration-resistant prostate cancer patien.Minerva Urology and Nephrology, , 74 (6 ) ,791-793 More Information

Belladelli F.; Montorsi F.; Martini A. (11-01-2022. ) Metabolic syndrome, obesity and cancer risk.Current Opinion in Urology, , 32 (6 ) ,594-597 More Information

Fallara G.; Larcher A.; Rosiello G.; Raggi D.; Marandino L.; Martini A.; Basile G.; Colandrea G.; Cignoli D.; Belladelli F.; Re C.; Musso G.; Cei F.; Bertini R.; Briganti A.; Salonia A.; Montorsi F.; Necchi A.; Capitanio U. (11-01-2022. ) How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit th.World Journal of Urology, , 40 (11 ) ,2667-2673 More Information

Fallara G.; Robesti D.; Nocera L.; Raggi D.; Marandino L.; Belladelli F.; Montorsi F.; Malavaud B.; Ploussard G.; Necchi A.; Martini A. (11-01-2022. ) Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive pro.Cancer Treatment Reviews, , 110 , More Information

Peters M.; Eldred-Evans D.; Kurver P.; Falagario U.G.; Connor M.J.; Shah T.T.; Verhoeff J.J.C.; Taimen P.; Aronen H.J.; Knaapila J.; Montoya Perez I.; Ettala O.; Stabile A.; Gandaglia G.; Fossati N.; Martini A.; Cucchiara V.; Briganti A.; Lantz A.; Picker W.; Haug E.S.; Nordström T.; Tanaka M.B.; Reddy D.; Bass E.; van Rossum P.S.N.; Wong K.; Tam H.; Winkler M.; Gordon S.; Qazi H.; Boström P.J.; Jambor I.; Ahmed H.U. (11-01-2022. ) Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a M.European Urology, , 82 (5 ) ,559-568 More Information

Martini A.; Mottet N.; Montorsi F.; Necchi A.; Ribal M.J.; Malavaud B. (11-01-2022. ) A Plea for Economically Sustainable Evidence-based Guidelines.European Urology, , 82 (5 ) ,449-451 More Information

Fallara G.; Belladelli F.; Robesti D.; Raggi D.; Nocera L.; Marandino L.; Galsky M.D.; Montorsi F.; Malavaud B.; Ploussard G.; Necchi A.; Martini A. (11-01-2022. ) Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castr.Critical Reviews in Oncology/Hematology, , 179 , More Information

Padua T.C.d.; Moschini M.; Martini A.; Pederzoli F.; Nocera L.; Marandino L.; Raggi D.; Briganti A.; Montorsi F.; Necchi A. (10-01-2022. ) Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: .Urologic Oncology: Seminars and Original Investigations, , 40 (10 ) ,413-423 More Information

Martini A.; Bravi C.A. (10-01-2022. ) Acute kidney injury and functional outcomes after partial nephrectomy.International Journal of Urology, , 29 (10 ) ,1243-1244 More Information

Cignoli D.; Fallara G.; Aleotti F.; Larcher A.; Rosiello G.; Rowe I.; Basile G.; Colandrea G.; Martini A.; De Cobelli F.; Brembilla G.; Lucianò R.; Colecchia M.; Lena M.S.; Partelli S.; Tamburrino D.; Zamboni G.; Rubini C.; Falconi M.; Montorsi F.; Salonia A.; Capitanio U. (10-01-2022. ) Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression.World Journal of Urology, , 40 (10 ) ,2481-2488 More Information

Nocera L.; Fallara G.; Raggi D.; Belladelli F.; Robesti D.; Montorsi F.; Karakiewicz P.I.; Malavaud B.; Ploussard G.; Necchi A.; Martini A. (09-05-2022. ) Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed sur.Frontiers in Oncology, , 12 , More Information

Martini A.; Fallara G.; Ploussard G.; Pradere B. (09-01-2022. ) Progression-free survival is an adequate endpoint for clinical trials of locally advanced and metast.Current Opinion in Urology, , 32 (5 ) ,500-503 More Information

Martini A.; Shah Q.N.; Waingankar N.; Sfakianos J.P.; Tsao C.K.; Necchi A.; Montorsi F.; Gallagher E.J.; Galsky M.D. (09-01-2022. ) The obesity paradox in metastatic castration-resistant prostate cancer.Prostate Cancer and Prostatic Diseases, , 25 (3 ) ,472-478 More Information

Lonati C.; Baumeister P.; Afferi L.; Mari A.; Minervini A.; Krajewski W.; Azizi S.; Hendricksen K.; Martini A.; Necchi A.; Montorsi F.; Briganti A.; Colombo R.; Tafuri A.; Antonelli A.; Cerruto M.A.; Rouprêt M.; Masson-Lecomte A.; Laukhtina E.; D'Andrea D.; Shariat S.F.; Soria F.; Marra G.; Gontero P.; Contieri R.; Hurle R.; Valiquette A.S.; Mir M.C.; Zamboni S.; Simeone C.; Klatte T.; Teoh J.Y.C.; Yoshida S.; Fujii Y.; Carando R.; Schulz G.B.; Mordasini L.; Mattei A.; Moschini M. (09-01-2022. ) Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Ca.European Urology Focus, , 8 (5 ) ,1270-1277 More Information

Mercuri S.R.; Paolino G.; Brianti P.; Di Nicola M.R.; Martini A.; Necchi A.; Montorsi F. (08-05-2022. ) UltraPulse Carbon Dioxide Laser Plus Methyl Aminolevulinate-Photodynamic Therapy for the Treatment o.Case Reports in Dermatology, , 14 (2 ) ,210-213 More Information

Martini A.; Lonati C.; Nocera L.; Fallara G.; Raggi D.; Herout R.; Zamboni S.; Ploussard G.; Predere B.; Mattei A.; Simeone C.; Krajewski W.; Simone G.; Soria F.; Gontero P.; Roupret M.; Montorsi F.; Briganti A.; Shariat S.F.; Necchi A.; Moschini M. (08-01-2022. ) Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial Carcino.European urology oncology, , 5 (4 ) ,451-459 More Information

Martini A.; Fallara G.; Pellegrino A.A.; Nocera L.; Larcher A.; Raggi D.; Campi R.; Ploussard G.; Malavaud B.; Montorsi F.; Pal S.K.; Spiess P.E.; Choueiri T.K.; Necchi A.; Capitanio U. (08-01-2022. ) Multidisciplinary team referral at diagnosis for patients with non-metastatic renal cell carcinoma.Urologic Oncology: Seminars and Original Investigations, , 40 (8 ) ,384.e9-384.e14 More Information

Basile G.; Rosiello G.; Larcher A.; Fallara G.; Martini A.; Re C.; Cignoli D.; Tian Z.; Karakiewicz P.I.; Mottrie A.; Bertini R.; Necchi A.; Raggi D.; Salonia A.; Briganti A.; Montorsi F.; Capitanio U. (08-01-2022. ) Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell c.Urologic Oncology: Seminars and Original Investigations, , 40 (8 ) ,384.e15-384.e21 More Information

Capitanio U.; Fallara G.; Raggi D.; Nocera L.; Larcher A.; Belladelli F.; Rowe I.; Briganti A.; Salonia A.; Karakiewicz P.; Montorsi F.; Martini A.; Necchi A. (08-01-2022. ) Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence.Current Problems in Cancer, , 46 (4 ) , More Information

Martini A.; Ploussard G. (08-01-2022. ) Re: Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 .European Urology, , 82 (2 ) ,241 More Information

Martini A.; Lonati C.; Necchi A.; Galsky M.D.; Ploussard G.; Fallara G.; Pellegrino A.; Simeone C.; Suardi N.; Zamboni S.; Krajewski W.; Simone G.; Briganti A.; Montorsi F.; Mattei A.; Shariat S.F.; Moschini M. (08-01-2022. ) Metastasis Within Three Years from Radical Nephroureterectomy as a Potential Surrogate for Overall S.Clinical Genitourinary Cancer, , 20 (4 ) ,389.e1-389.e7 More Information

Martini A.; Yu M.; Raggi D.; Joshi H.; Fallara G.; Montorsi F.; Necchi A.; Galsky M.D. (08-01-2022. ) Adjuvant immunotherapy in patients with high-risk muscle-invasive urothelial carcinoma: The potentia.Cancer, , 128 (15 ) ,2892-2897 More Information

Rosiello G.; Re C.; Larcher A.; Fallara G.; Sorce G.; Baiamonte G.; Mazzone E.; Bravi C.A.; Martini A.; Tian Z.; Mottrie A.; Bertini R.; Salonia A.; Briganti A.; Montorsi F.; Capitanio U.; Karakiewicz P.I. (08-01-2022. ) The effect of frailty on post-operative outcomes and health care expenditures in patients treated wi.European Journal of Surgical Oncology, , 48 (8 ) ,1840-1847 More Information

Parekh S.; Ratnani P.; Falagario U.; Lundon D.; Kewlani D.; Nasri J.; Dovey Z.; Stroumbakis D.; Ranti D.; Grauer R.; Sobotka S.; Pedraza A.; Wagaskar V.; Mistry L.; Jambor I.; Lantz A.; Ettala O.; Stabile A.; Taimen P.; Aronen H.J.; Knaapila J.; Perez I.M.; Gandaglia G.; Martini A.; Picker W.; Haug E.; Cormio L.; Nordström T.; Briganti A.; Boström P.J.; Carrieri G.; Haines K.; Gorin M.A.; Wiklund P.; Menon M.; Tewari A. (07-01-2022. ) The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Signific.European Urology Open Science, , 41 ,45-54 More Information

Martini A.; Raggi D.; Marandino L.; Montorsi F.; Ross J.S.; Gibb E.A.; Necchi A. (06-01-2022. ) The Paradoxical Role of Body Mass Index in Patients with Muscle-invasive Bladder Cancer Receiving Ne.European urology oncology, , 5 (3 ) ,370-372 More Information

Martini A.; Lonati C.; Montorsi F.; Briganti A.; Colombo R.; Necchi A.; Simeone C.; Zamboni S.; Afferi L.; Mattei A.; Carando R.; Ploussard G.; Soria F.; Marra G.; Rouprêt M.; Xylinas E.; Pradere B.; Abufaraj M.; D'Andrea D.; Shariat S.F.; Moschini M. (06-01-2022. ) The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy.Clinical Genitourinary Cancer, , 20 (3 ) ,e190-e198 More Information

Rosiello G.; Larcher A.; Fallara G.; Giancristofaro C.; Martini A.; Re C.; Cei F.; Musso G.; Tian Z.; Karakiewicz P.I.; Mottrie A.; Bertini R.; Salonia A.; Necchi A.; Raggi D.; Briganti A.; Montorsi F.; Capitanio U. (06-01-2022. ) Head-to-head comparison of all the prognostic models recommended by the European Association of Urol.Urologic Oncology: Seminars and Original Investigations, , 40 (6 ) ,271.e19-271.e27 More Information

Lonati C.; Afferi L.; Mari A.; Minervini A.; Krajewski W.; Borghesi M.; Schulz G.B.; Rink M.; Montorsi F.; Briganti A.; Colombo R.; Martini A.; Necchi A.; Contieri R.; Hurle R.; Umari P.; Zamboni S.; Simeone C.; Soria F.; Marra G.; Gontero P.; Teoh J.Y.C.; Klatte T.; Bajeot A.S.; Roumiguié M.; Rouprêt M.; Masson-Lecomte A.; Laukhtina E.; Valiquette A.S.; Mir M.C.; Antonelli A.; Einerhand S.M.H.; Hendricksen K.; Carando R.; Fankhauser C.D.; Baumeister P.; Mattei A.; Shariat S.F.; Moschini M. (05-01-2022. ) Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous.World Journal of Urology, , 40 (5 ) ,1167-1174 More Information

Lantz A.; Falagario U.G.; Ratnani P.; Jambor I.; Dovey Z.; Martini A.; Lewis S.; Lundon D.; Nair S.; Phillip D.; Haines K.; Cormio L.; Carrieri G.; Kryprianou N.; Tewari A. (04-01-2022. ) Expanding Active Surveillance Inclusion Criteria: A Novel Nomogram Including Preoperative Clinical P.European urology oncology, , 5 (2 ) ,187-194 More Information

Martini A.; Touzani A.; Mazzone E.; Roumiguié M.; Marra G.; Valerio M.; Beauval J.B.; Campi R.; Minervini A.; van den Berg R.C.N.; van den Berg R.C.N.; Soeterik T.F.W.; Zhuang J.; Guo H.; Gontero P.; Montorsi F.; Briganti A.; Gandaglia G.; Ploussard G. (04-01-2022. ) Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions.Prostate Cancer and Prostatic Diseases, , 25 (4 ) ,794-796 More Information

Martini A.; Falagario U.G.; Cumarasamy S.; Jambor I.; Wagaskar V.G.; Ratnani P.; Haines K.G.; Tewari A.K. (03-01-2022. ) The Role of 3D Models Obtained from Multiparametric Prostate MRI in Performing Robotic Prostatectomy.Journal of Endourology, , 36 (3 ) ,387-393 More Information

Montorsi F.; Martini A.; Gandaglia G.; Fossati N.; Stabile A.; Dehò F.; Salonia A.; Briganti A. (03-01-2022. ) Metastatic hormone-sensitive prostate cancer: local treatment strategies.World Journal of Urology, , 40 (3 ) ,881-882 More Information

Rosiello G.; Gandaglia G.; Scuderi S.; Barletta F.; Fossati N.; Stabile A.; Gallina A.; Mazzone E.; Vitale L.M.; Pellegrino A.; Bravi C.; Martini A.; Cucchiara V.; Karakiewicz P.I.; Mottrie A.; Briganti A.; Montorsi F. (03-01-2022. ) Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prost.European Urology Focus, , 8 (2 ) ,431-437 More Information

Martini A.; Raggi D.; Fallara G.; Nocera L.; Schultz J.G.; Belladelli F.; Marandino L.; Salonia A.; Briganti A.; Montorsi F.; Powles T.; Necchi A. (03-01-2022. ) Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systemat.Cancer Treatment Reviews, , 104 , More Information

Dovey Z.; Pfail J.; Martini A.; Steineck G.; Dey L.; Renström L.; Hosseini A.; Sfakianos J.P.; Wiklund P. (03-01-2022. ) Bladder Cancer (NMIBC) in a population-based cohort from Stockholm County with long-term follow-up; .Urologic Oncology: Seminars and Original Investigations, , 40 (3 ) ,106.e1-106.e10 More Information

Tafuri A.; Sandri M.; Martini A.; Capitanio U.; Mantica G.; Terrone C.; Furlan M.; Simeone C.; Amparore D.; Porpiglia F.; Minervini A.; Mari A.; Cerruto M.A.; Antonelli A. (02-01-2022. ) External validation of the Palacios’ equation: a simple and accurate tool to estimate the new baseli.World Journal of Urology, , 40 (2 ) ,467-473 More Information

Montoya Perez I.; Merisaari H.; Jambor I.; Ettala O.; Taimen P.; Knaapila J.; Kekki H.; Khan F.L.; Syrjälä E.; Steiner A.; Syvänen K.T.; Verho J.; Seppänen M.; Rannikko A.; Riikonen J.; Mirtti T.; Lamminen T.; Saunavaara J.; Falagario U.; Martini A.; Pahikkala T.; Pettersson K.; Boström P.J.; Aronen H.J. (02-01-2022. ) Detection of Prostate Cancer Using Biparametric Prostate MRI, Radiomics, and Kallikreins: A Retrospe.Journal of Magnetic Resonance Imaging, , 55 (2 ) ,465-477 More Information

Martini A.; Soeterik T.F.W.; Haverdings H.; Rahota R.G.; Checcucci E.; De Cillis S.; Hermanns T.; Fankhauser C.D.; Afferi L.; Moschini M.; Mattei A.; Kesch C.; Heidegger I.; Preisser F.; Zattoni F.; Marquis A.; Marra G.; Gontero P.; Briganti A.; Montorsi F.; Porpiglia F.; Van Basten J.P.; Van Den Bergh R.C.N.; Van Melick H.H.E.; Ploussard G.; Gandaglia G.; Valerio M. (02-01-2022. ) An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate Cancer.Journal of Urology, , 207 (2 ) ,350-357 More Information

Lonati C.; Necchi A.; Gómez Rivas J.; Afferi L.; Laukhtina E.; Martini A.; Ventimiglia E.; Colombo R.; Gandaglia G.; Salonia A.; Briganti A.; Montorsi F.; Mattei A.; Simeone C.; Carlo M.I.; Shariat S.F.; Spiess P.E.; Moschini M. (02-01-2022. ) Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview fro.European urology oncology, , 5 (1 ) ,30-41 More Information

Lobo N.; Martini A.; Kamat A.M. (01-01-2022. ) Evolution of immunotherapy in the treatment of non-muscle-invasive bladder cancer.Expert Review of Anticancer Therapy, , 22 (4 ) ,361-370 More Information

Kretschmer A.; Van Den Bergh R.C.N.; Martini A.; Marra G.; Valerio M.; Tsaur I.; Heidegger I.; Kasivisvanathan V.; Kesch C.; Preisser F.; Fankhauser C.D.; Zattoni F.; Ceci F.; Olivier J.; Chiu P.; Puche-Sanz I.; Thibault C.; Gandaglia G.; Tilki D. (01-01-2022. ) Assessment of health-related quality of life in patients with advanced prostate cancer—current state.Cancers, , 14 (1 ) , More Information

Necchi A.; Martini A.; Raggi D.; Cucchiara V.; Colecchia M.; Lucianò R.; Villa L.; Mazzone E.; Basile G.; Scuderi S.; Pederzoli F.; Bandini M.; Barletta F.; Larcher A.; Capitanio U.; Salonia A.; Briganti A.; Ross J.S.; Messina A.; Montorsi F. (01-01-2022. ) A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with.Urologic Oncology: Seminars and Original Investigations, , 40 (1 ) ,10.e1-10.e6 More Information

Cirulli G.O.; Larcher A.; Montorsi F.; Martini A. (01-01-2022. ) Metabolic Syndrome, Obesity and Cancer Risk.Men’s Health and Wellbeing, , 95-119 More Information

Rocco B.; Martini A.; Sighinolfi M.C.; Ko Y.H. (01-01-2022. ) Techniques to Improve Urinary Continence Outcomes Following Robot-Assisted Radical Prostatectomy.Robotic Urologic Surgery: Third Edition, , 217-223 More Information

Wagaskar V.G.; Barthe F.; Martini A.; Sooriakumaran P.; Tewari A. (01-01-2022. ) Oligometastatic prostate cancer: a new horizon for robotic radical prostatectomy.Mini-invasive Surgery, , 6 , More Information

Martini A.; Montorsi F. (01-01-2022. ) The Future of Artificial Intelligence Applied to Perioperative Immunotherapy Trials: Prostate Cancer.Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers: Multidisciplinary Management, , 295-297 More Information

Martini A.; Larcher A. (01-01-2022. ) The Future of Artificial Intelligence Applied to Perioperative Immunotherapy Trials: Renal Cell Carc.Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers: Multidisciplinary Management, , 299-302 More Information

Falagario U.G.; Jambor I.; Lantz A.; Ettala O.; Stabile A.; Taimen P.; Aronen H.J.; Knaapila J.; Perez I.M.; Gandaglia G.; Fossati N.; Martini A.; Cucchiara V.; Picker W.; Haug E.; Ratnani P.; Haines K.; Lewis S.; Sujit N.; Selvaggio O.; Sanguedolce F.; Macarini L.; Cormio L.; Nordström T.; Tewari A.; Briganti A.; Boström P.J.; Carrieri G. (12-01-2021. ) Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy.European urology oncology, , 4 (6 ) ,971-979 More Information

Martini A.; Turri F.; Barod R.; Rocco B.; Capitanio U.; Briganti A.; Montorsi F.; Mottrie A.; Challacombe B.; Lagerveld B.W.; Bensalah K.; Abaza R.; Badani K.K.; Mehrazin R.; Buscarini M.; Larcher A.; Okhawere K.; Martinez O.E.; Khene Z.E.; Sonpreet R.; Campain N.; De Groote R.; Dell'Oglio P.; Grivas N.; Goonewardene S.; Hemal A.; Rivas J.G. (12-01-2021. ) Salvage Robot-assisted Renal Surgery for Local Recurrence After Surgical Resection or Renal Mass Abl.European Urology, , 80 (6 ) ,730-737 More Information

Martini A.; Gandaglia G.; Briganti A. (11-01-2021. ) Evidence-based Urology: Surrogate Endpoints – For.European Urology Focus, , 7 (6 ) ,1217-1218 More Information

Marandino L.; Raggi D.; Calareso G.; Alessi A.; Colecchia M.; Martini A.; Briganti A.; Montorsi F.; Madison R.; Ross J.S.; Necchi A. (10-01-2021. ) Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemother.Clinical Genitourinary Cancer, , 19 (5 ) ,457-465 More Information

Martini A.; Afferi L.; Zamboni S.; Schultz J.G.; Lonati C.; Mattei A.; Karnes R.J.; Soligo M.; Stabile A.; Di Trapani E.; De Cobelli O.; Simone G.; Simeone C.; Alvarez-Maestro M.; Gandaglia G.; Gallina A.; Colombo R.; Briganti A.; Montorsi F.; Xylinas E.; Shariat S.F.; Moschini M. (10-01-2021. ) Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy.Journal of Urology, , 206 (4 ) ,885-893 More Information

Martini A.; Parikh A.B.; Sfakianos J.P.; Montorsi F.; Galsky M.D.; Oh W.K.; Tsao C.K. (09-01-2021. ) Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-.Prostate Cancer and Prostatic Diseases, , 24 (3 ) ,743-749 More Information

Moschini M.; Afferi L.; Gandaglia G.; D'Andrea D.; Zamboni S.; Di Bona C.; Mordasini L.; Mattei A.; Baumeister P.; Martini A.; Burgio G.; Shariat S.F.; Sanchez-Salas R.; Cathelineau X.; Stabile A.; Zaffuto E.; Salonia A.; Colombo R.; Necchi A.; Montorsi F.; Briganti A.; Gallina A. (09-01-2021. ) Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients.European Urology Focus, , 7 (5 ) ,1067-1074 More Information

Wagaskar V.G.; Mittal A.; Sobotka S.; Ratnani P.; Lantz A.; Falagario U.G.; Martini A.; Dovey Z.; Treacy P.J.; Pathak P.; Nair S.; Roy B.; Chakravarty D.; Lewis S.; Haines K.; Wiklund P.; Tewari A. (08-01-2021. ) Hood Technique for Robotic Radical Prostatectomy—Preserving Periurethral Anatomical Structures in th.European Urology, , 80 (2 ) ,213-221 More Information

Di Marco F.; Pani A.; Floris M.; Martini A.; Dell’antonio G.; Capitanio U.; Bettiga A.; Larcher A.; Cinque A.; Bertini R.; Briganti A.; Salonia A.; Montorsi F.; Trevisani F. (08-01-2021. ) Unexpected outcomes of renal function after radical nephrectomy: Histology relevance along with clin.Journal of Clinical Medicine, , 10 (15 ) , More Information

BRAVI C.A.; ROSIELLO G.; FALLARA G.; VERTOSICK E.; TIN A.; SJOBERG D.; BIANCHI M.; MAZZONE E.; MARTINI A.; DELL'OGLIO P.; STABILE A.; GANDAGLIA G.; FOSSATI N.; BRIGANTI A.; MONTORSI F.; VICKERS A. (08-01-2021. ) Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: Result.Minerva Urology and Nephrology, , 73 (4 ) ,481-488 More Information

Martini A.; Larcher A.; Bravi C.A.; Capogrosso P.; Falagario U.G.; Fallara G.; Pellegrino F.; Muttin F.; Re C.; Briganti A.; Salonia A.; Bertini R.; Montorsi F.; Capitanio U. (06-01-2021. ) How to Select the Optimal Candidates for Renal Mass Biopsy.European urology oncology, , 4 (3 ) ,506-509 More Information

Martini A.; Falagario U.G.; Cumarasamy S.; Abaza R.; Eun D.D.; Bhandari A.; Porter J.R.; Hemal A.K.; Badani K.K. (06-01-2021. ) Defining Risk Categories for a Significant Decline in Estimated Glomerular Filtration Rate After Rob.European Urology Oncology, , 4 (3 ) ,498-501 More Information

Martini A.; Fallara G.; Pellegrino F.; Cirulli G.O.; Larcher A.; Necchi A.; Montorsi F.; Capitanio U. (05-01-2021. ) Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma.World Journal of Urology, , 39 (5 ) ,1369-1376 More Information

Veccia A.; Falagario U.; Martini A.; Marchioni M.; Antonelli A.; Simeone C.; Cormio L.; Capitanio U.; Mir M.C.; Derweesh I.; Van Poppel H.; Porpiglia F.; Autorino R. (05-01-2021. ) Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Syst.European Urology Focus, , 7 (3 ) ,574-581 More Information

Pfail J.L.; Katims A.B.; Gul Z.; Rosenzweig S.J.; Razdan S.; Nathaniel S.; Martini A.; Mehrazin R.; Wiklund P.N.; Loftus K.; Sim A.; DeMaria S.; Sfakianos J.P. (04-01-2021. ) Can anesthetics affect bladder cancer recurrence? Total intravenous versus volatile anesthesia in pa.Urologic Oncology: Seminars and Original Investigations, , 39 (4 ) ,233.e1-233.e8 More Information

Montorsi F.; Martini A. (04-01-2021. ) Re: Mathieu Rouanne, Dean F. Bajorin, Raquibul Hannan, et al. Rationale and Outcomes for Neoadjuvant.European urology oncology, , 4 (2 ) ,336 More Information

Martini A.; Fossati N.; Karnes R.J.; Boorjian S.A.; Boeri L.; Bossi A.; Di Muzio N.; Cozzarini C.; Noris Chiorda B.; Gandaglia G.; Robesti D.; Bartkowiak D.; Böhmer D.; Shariat S.F.; Goldner G.; Battaglia A.; Joniau S.; Berghen C.; De Meerleer G.; Fonteyne V.; Ost P.; Van Poppel H.; Montorsi F.; Wiegel T.; Briganti A. (04-01-2021. ) Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radi.European urology oncology, , 4 (2 ) ,301-304 More Information

Martini A.; Gandaglia G.; Fossati N.; Scuderi S.; Bravi C.A.; Mazzone E.; Stabile A.; Scarcella S.; Robesti D.; Barletta F.; Cucchiara V.; Mirone V.; Montorsi F.; Briganti A. (02-01-2021. ) Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectom.European urology oncology, , 4 (1 ) ,42-48 More Information

Falagario U.G.; Lantz A.; Jambor I.; Martini A.; Ratnani P.; Wagaskar V.; Treacy P.J.; Veccia A.; Bravi C.A.; Bashorun H.O.; Phillip D.; Lewis S.; Haines K.; Cormio L.; Carrieri G.; Tewari A. (01-01-2021. ) Using biomarkers in patients with positive multiparametric magnetic resonance imaging: 4Kscore predi.International Journal of Urology, , 28 (1 ) ,47-52 More Information

Martini A.; Falagario U.G.; Bravi C.A.; Abaza R.; Eun D.D.; Bhandari A.; Porter J.R.; Capitanio U.; Montorsi F.; Hemal A.K.; Badani K.K. (01-01-2021. ) Editorial Comment from Dr Martini et al. to Independent external validation of a nomogram to define .International Journal of Urology, , 28 (1 ) ,80-81 More Information

Martini A.; Gandaglia G.; Nicita G.; Montorsi F. (01-01-2021. ) RE: Validating the Martini Staging System for Rectourethral Fistula: A Meta-analysis of Postoperativ.Urology, , 147 ,323 More Information

Martini A. (01-01-2021. ) On the use of the “Population Attributable Fraction”: application in cost estimation.Translational Andrology and Urology, , 10 (1 ) ,22-23 More Information

Falagario U.G.; Jambor I.; Ratnani P.; Martini A.; Treacy P.J.; Wajswol E.; Lantz A.; Papastefanou G.; Weil R.; Phillip D.; Lewis S.; Haines K.; Cormio L.; Carrieri G.; Kyprianou N.; Wiklund P.; Tewari A.K. (12-01-2020. ) Performance of prostate multiparametric Mri for prediction of prostate cancer extra-prostatic extens.Minerva Urologica e Nefrologica, , 72 (6 ) ,746-754 More Information

Gandaglia G.; Ploussard G.; Valerio M.; Marra G.; Moschini M.; Martini A.; Roumiguié M.; Fossati N.; Stabile A.; Beauval J.B.; Malavaud B.; Scuderi S.; Barletta F.; Afferi L.; Rakauskas A.; Gontero P.; Mattei A.; Montorsi F.; Briganti A. (12-01-2020. ) Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Bio.European urology oncology, , 3 (6 ) ,739-747 More Information

Anastos H.; Martini A.; Waingankar N.; Paulucci D.J.; Beksac A.T.; Daza J.; Patel H.V.; Gin G.E.; Sfakianos J.P.; Badani K.K. (12-01-2020. ) Black race may be associated with worse overall survival in renal cell carcinoma patients.Urologic Oncology: Seminars and Original Investigations, , 38 (12 ) ,938.e9-938.e17 More Information

Martini A.; Pfail J.; Montorsi F.; Galsky M.D.; Oh W.K. (12-01-2020. ) Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate can.Prostate Cancer and Prostatic Diseases, , 23 (4 ) ,638-645 More Information

Veccia A.; Antonelli A.; Martini A.; Falagario U.; Carrieri G.; Grob M.B.; Guruli G.; Simeone C.; Wiklund P.; Porpiglia F.; Autorino R. (11-01-2020. ) Ureteral location is associated with survival outcomes in upper tract urothelial carcinoma: A popula.International Journal of Urology, , 27 (11 ) ,966-972 More Information

Villari D.; Salvianti F.; Zanazzi M.; Martini A.; Spatafora P.; Caroassai Grisanti S.; Sebastianelli A.; Nicita G.; Serni S.; Pinzani P. (11-01-2020. ) Quantitative Polymerase Chain Reaction Detection of Microchimerism in Female Transplant Renal Recipi.Urologia Internationalis, , 104 (11-12 ) ,865-870 More Information

Jambor I.; Falagario U.G.; Martini A.; Eldred-Evans D.; Ahmed H.U.; Boström P.J. (10-01-2020. ) Re: Antonio C. Westphalen, Charles E. McCulloch, Jordan M. Anaokar, et al. Variability of the Positi.European urology oncology, , 3 (5 ) ,714-715 More Information

Falagario U.G.; Martini A.; Wajswol E.; Treacy P.J.; Ratnani P.; Jambor I.; Anastos H.; Lewis S.; Haines K.; Cormio L.; Carrieri G.; Rastinehad A.R.; Wiklund P.; Tewari A. (10-01-2020. ) Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive.European urology oncology, , 3 (5 ) ,700-704 More Information

Martini A.; Falagario U.G.; Villers A.; Dell'Oglio P.; Mazzone E.; Autorino R.; Moschovas M.C.; Buscarini M.; Bravi C.A.; Briganti A.; Sawczyn G.; Kaouk J.; Menon M.; Secco S.; Bocciardi A.M.; Wang G.; Zhou X.; Porpiglia F.; Mottrie A.; Patel V.; Tewari A.K.; Montorsi F.; Gaston R.; Wiklund N.P.; Hemal A.K. (10-01-2020. ) Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy.European Urology, , 78 (4 ) ,583-591 More Information

Gandaglia G.; Martini A.; Ploussard G.; Fossati N.; Stabile A.; De Visschere P.; Borgmann H.; Heidegger I.; Steinkohl F.; Kretschmer A.; Marra G.; Mathieu R.; Surcel C.; Tilki D.; Tsaur I.; Valerio M.; Van den Bergh R.; Ost P.; Gontero P.; Montorsi F.; Briganti A. (08-01-2020. ) External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients.European Urology, , 78 (2 ) ,138-142 More Information

Martini A.; Falagario U.G.; Waingankar N.; Daza J.; Treacy P.J.; Necchi A.; Galsky M.D.; Sfakianos J.P. (08-01-2020. ) Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma.Urologic Oncology: Seminars and Original Investigations, , 38 (8 ) ,684.e9-684.e15 More Information

Falagario U.G.; Ratnani P.; Lantz A.; Jambor I.; Dovey Z.; Verma A.; Treacy P.J.; Sobotka S.; Martini A.; Bashorun H.; Ashan M.; Wagaskar V.G.; Lewis S.; Cormio L.; Carrieri G.; Kyprianou N.; Mohamed N.; Tewari A. (07-01-2020. ) Staging Accuracy of Multiparametric Magnetic Resonance Imaging in Caucasian and African American Men.Journal of Urology, , 204 (1 ) ,82-89 More Information

Falagario U.G.; Martini A.; Pfail J.; Treacy P.J.; Okhawere K.E.; Dayal B.D.; Sfakianos J.P.; Abaza R.; Eun D.D.; Bhandari A.; Porter J.R.; Hemal A.K.; Badani K.K. (04-01-2020. ) Does race impact functional outcomes in patients undergoing robotic partial nephrectomy?.Translational Andrology and Urology, , 9 (2 ) ,863-869 More Information

Wajswol E.; Winoker J.S.; Anastos H.; Falagario U.; Okhawere K.; Martini A.; Treacy P.J.; Voutsinas N.; Knauer C.J.; Sfakianos J.P.; Lewis S.C.; Taouli B.A.; Rastinehad A.R. (04-01-2020. ) A cohort of transperineal electromagnetically tracked magnetic resonance imaging/ultrasonography fus.BJU International, , 125 (4 ) ,531-540 More Information

Jambor I.; Falagario U.; Ratnani P.; Perez I.M.; Demir K.; Merisaari H.; Sobotka S.; Haines G.K.; Martini A.; Beksac A.T.; Lewis S.; Pahikkala T.; Wiklund P.; Nair S.; Tewari A. (04-01-2020. ) Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using r.Journal of Magnetic Resonance Imaging, , 51 (4 ) ,1075-1085 More Information

Cumarasamy S.; Martini A.; Falagario U.G.; Gul Z.; Beksac A.T.; Jayaratna I.; Haines G.K.; Carrieri G.; Tewari A. (04-01-2020. ) Development of a model to predict prostate cancer at the apex (PCAP model) in patients undergoing ro.World Journal of Urology, , 38 (4 ) ,813-819 More Information

Martini A.; Marqueen K.E.; Falagario U.G.; Waingankar N.; Wajswol E.; Khan F.; Fossati N.; Briganti A.; Montorsi F.; Tewari A.K.; Stock R.; Rastinehad A.R. (03-31-2020. ) Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prost.JAMA Network Open, , 3 (3 ) ,E201913 More Information

Waingankar N.; Martini A.; Griffiths L.; Shah P.; Paulucci D.J.; Kotamarti S.; Gul Z.; Elmasri M.; Yaskiv O.; Haines K.; Lerner S.; Vira M.; Kavoussi L.R.; Tewari A.K.; Kapoor D.A.; Olsson C.A. (03-01-2020. ) Weighted Gleason Grade Group (WGGG): A new prostate cancer biopsy reporting system with prognostic p.Urologic Oncology: Seminars and Original Investigations, , 38 (3 ) ,78.e15-78.e21 More Information

Martini A.; Sfakianos J.P.; Renström-Koskela L.; Mortezavi A.; Falagario U.G.; Egevad L.; Hosseini A.; Mehrazin R.; Galsky M.D.; Steineck G.; Wiklund N.P. (02-01-2020. ) The natural history of untreated muscle-invasive bladder cancer.BJU International, , 125 (2 ) ,270-275 More Information

Tam A.W.; Liaw C.; Li E.; Katims A.B.; Say R.K.; Gul Z.; Winoker J.S.; Martini A.; Audenet F.; Sfakianos J.P. (01-01-2020. ) The effect of tumor location on overall survival for pT2-4 bladder and upper tract urothelial carcin.Canadian Urological Association Journal, , 15 (5 ) , More Information

Pfail J.L.; Audenet F.; Martini A.; Tomer N.; Paranjpe I.; Daza J.; Attalla K.; Waingankar N.; Mehrazin R.; Wiklund P.; Galsky M.D.; Sfakianos J.P. (01-01-2020. ) Survival of patients with muscle-invasive urothelial cancer of the bladder with residual disease at .Bladder Cancer, , 6 (3 ) ,265-276 More Information

Moschini M.; Martini A.; Zamboni S.; Mattei A.; Baumeister P.; Di Bona C.; Dell'Oglio P.; Zaffuto E.; Burgio G.; Shariat S.F.; Sanchez-Salas R.; Cathelineau X.; Salonia A.; Montorsi F.; Briganti A.; Gallina A.; Colombo R. (12-01-2019. ) Re: Evaluation of Cause of Death after Radical Cystectomy for Patients with Bladder Cancer: The Impa.Journal of Urology, , 202 (6 ) ,1076-1077 More Information

Niglio S.A.; Jia R.; Ji J.; Ruder S.; Patel V.G.; Martini A.; Sfakianos J.P.; Marqueen K.E.; Waingankar N.; Mehrazin R.; Wiklund P.; Oh W.K.; Mazumdar M.; Ferket B.S.; Galsky M.D. (12-01-2019. ) Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metasta.European Urology, , 76 (6 ) ,782-789 More Information

Wang L.; Gong Y.; Saci A.; Szabo P.M.; Martini A.; Necchi A.; Siefker-Radtke A.; Pal S.; Plimack E.R.; Sfakianos J.P.; Bhardwaj N.; Horowitz A.; Farkas A.M.; Mulholland D.; Fischer B.S.; Oh W.K.; Sharma P.; Zhu J.; Galsky M.D. (11-01-2019. ) Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with.European Urology, , 76 (5 ) ,599-603 More Information

Martini A.; Sfakianos J.P.; Galsky M.D. (10-01-2019. ) Conditionally Reprogrammed Patient-derived Cells: A Step Forward Towards Personalized Medicine?.European Urology, , 76 (4 ) ,435-436 More Information

Gul Z.G.; Martini A.; Olsson C.A. (10-01-2019. ) Re: Jacob A. Burns, Adam B. Weiner, William J. Catalone, et al. Inflammatory Bowel Disease and the R.European Urology, , 76 (4 ) ,e98 More Information

Martini A.; Daza J.; Poltiyelova E.; Gul Z.; Heard J.R.; Ferket B.S.; Waingankar N.; Galsky M.D.; Sfakianos J.P. (10-01-2019. ) Pathological downstaging as a novel endpoint for the development of neoadjuvant chemotherapy for upp.BJU International, , 124 (4 ) ,665-671 More Information

Martini A.; Cumarasamy S.; Gupta A.; Falagario U.G.; Shah Q.N.; Beksac A.T.; Haines K.G.; Tewari A.K. (10-01-2019. ) Clinical implications of prostatic capsular abutment or bulging on multiparametric magnetic resonanc.Minerva Urologica e Nefrologica, , 71 (5 ) ,502-507 More Information

Martini A.; Jia R.; Ferket B.S.; Waingankar N.; Plimack E.R.; Crabb S.J.; Harshman L.C.; Yu E.Y.; Powles T.; Rosenberg J.E.; Pal S.K.; Vaishampayan U.N.; Necchi A.; Wiklund N.P.; Mehrazin R.; Mazumdar M.; Sfakianos J.P.; Galsky M.D. (09-15-2019. ) Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy.Cancer, , 125 (18 ) ,3155-3163 More Information

Gupta S.S.; Martini A.; Wagaskar V.G.; Tewari A.K. (09-01-2019. ) Prostate Cancer in a Patient with Giant Prostatic Hyperplasia: The Robotic Approach to a Difficult P.Journal of Endourology Case Reports, , 5 (3 ) ,99-101 More Information

Falagario U.G.; Beksac A.T.; Martini A.; Cumarasamy S.; Gupta A.; Prasad S.; Thulasidass H.; Shah Q.N.; Jayaratna I.; Lewis S.; Rastinehad A.R.; Taouli B.; Cormio L.; Carrieri G.; Tewari A.K. (07-01-2019. ) Defining Prostate Cancer at Favorable Intermediate Risk: The Potential Utility of Magnetic Resonance.Journal of Urology, , 202 (1 ) ,102-106 More Information

Martini A.; Gandaglia G.; Karnes R.J.; Zaffuto E.; Bianchi M.; Gontero P.; Chlosta P.; Gratzke C.; Graefen M.; Tilki D.; Cucchiara V.; Mirone V.; Kneitz B.; Sanchez Salas R.; Van Der Poel H.; Tombal B.; Spahn M.; Joniau T.S.; Montorsi F.; Briganti A. (07-01-2019. ) Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Pat.European Urology Oncology, , 2 (4 ) ,456-463 More Information

Martini A.; Wang J.; Brown N.M.; Cumarasamy S.; Sfakianos J.P.; Rastinehad A.R.; Haines K.G.; Wiklund N.P.; Nair S.S.; Tewari A.K. (07-01-2019. ) A transcriptomic signature of tertiary Gleason 5 predicts worse clinicopathological outcome.BJU International, , 124 (1 ) ,155-162 More Information

Martini A.; Sfakianos J.P.; Paulucci D.J.; Abaza R.; Eun D.D.; Bhandari A.; Hemal A.K.; Badani K.K. (07-01-2019. ) Predicting acute kidney injury after robot-assisted partial nephrectomy: Implications for patient se.Urologic Oncology: Seminars and Original Investigations, , 37 (7 ) ,445-451 More Information

Bravi C.A.; Tin A.; Vertosick E.; Mazzone E.; Martini A.; Dell'oglio P.; Stabile A.; Gandaglia G.; Fossati N.; Suardi N.; Gallina A.; Briganti A.; Montorsi F.; Vickers A. (07-01-2019. ) The Impact of Experience on the Risk of Surgical Margins and Biochemical Recurrence after Robot-Assi.Journal of Urology, , 202 (1 ) ,108-113 More Information

Martini A.; Cumarasamy S.; Haines K.G.; Tewari A.K. (07-01-2019. ) An updated approach to incremental nerve sparing for robot-assisted radical prostatectomy.BJU International, , 124 (1 ) ,103-108 More Information

Moschini M.; Martini A.; Zamboni S.; Mattei A.; Baumeister P.; Di Bona C.; Dell'Oglio P.; Zaffuto E.; Burgio G.; Shariat S.F.; Sanchez-Salas R.; Cathelineau X.; Salonia A.; Montorsi F.; Briganti A.; Gallina A.; Colombo R. (06-01-2019. ) Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact o.Clinical Genitourinary Cancer, , 17 (3 ) ,e541-e548 More Information

Beksac A.T.; Sobotka S.; Xu P.; Gupta A.; Treacy P.J.; Weil R.; Mahajan K.; Prasad S.; Cumarasamy S.; Martini A.; Falagario U.; Rastinehad A.; Tewari A.K. (05-01-2019. ) Downgrading of Grade Group After Radical Prostatectomy: Comparison of Multiparametric Magnetic Reson.Urology, , 127 ,80-85 More Information

Martini A.; Gupta A.; Cumarasamy S.; Lewis S.C.; Haines K.G.; Briganti A.; Montorsi F.; Tewari A.K. (04-01-2019. ) Novel nomogram for the prediction of seminal vesicle invasion including multiparametric magnetic res.International Journal of Urology, , 26 (4 ) ,458-464 More Information

Martini A.; Gandaglia G.; Briganti A. (01-01-2019. ) What is new in robot-assisted radical prostatectomy: A narrative review.Current Opinion in Urology, , 29 (1 ) ,14-18 More Information

Martini A.; Wagaskar V.G.; Dell'oglio P.; Rastinehad A.R.; Sfakianos J.P.; Tewari A.K. (01-01-2019. ) Image guidance in robot-assisted radical prostatectomy: How far do we stand?.Current Opinion in Urology, , 29 (1 ) ,10-13 More Information

Villa L.; Capogrosso P.; Capitanio U.; Martini A.; Briganti A.; Salonia A.; Montorsi F. (01-01-2019. ) Silodosin: An Update on Efficacy, Safety and Clinical Indications in Urology.Advances in Therapy, , 36 (1 ) , More Information

Arroyo C.; Martini A.; Wang J.; Tewari A.K. (01-01-2019. ) Anatomical, surgical and technical factors influencing continence after radical prostatectomy.Therapeutic Advances in Urology, , 11 , More Information

Martini A.; Tewari A.K. (01-01-2019. ) Anatomic robotic prostatectomy: current best practice.Therapeutic Advances in Urology, , 11 , More Information

Beksac A.; Reddy B.; Martini A.; Paulucci D.; Moshier E.; Abaza R.; Eun D.; Hemal A.; Badani K. (01-01-2019. ) Hypertension and diabetes mellitus are not associated with worse renal functional outcome after part.International Journal of Urology, , 26 (1 ) ,120-125 More Information

Beksac A.T.; Paulucci D.J.; Gul Z.; Reddy B.N.; Kannappan M.; Martini A.; Sfafakianos J.P.; Gin G.E.; Abaza R.; Eun D.D.; Bhandari A.; Hemal A.K.; Porter J.; Badani K.K. (01-01-2019. ) Risk factors and prognostic implications for pathologic upstaging to T3a after partial nephrectomy.Minerva Urologica e Nefrologica, , 71 (4 ) ,395-405 More Information

Dr A.M.; Cumarasamy S.; Hemal A.K.; Badani K.K. (01-01-2019. ) Renal cell carcinoma: The oncological outcome is not the only endpoint.Translational Andrology and Urology, , 8 ,S93-S95 More Information

Martini A.; Gandaglia G.; Nicita G.; Montorsi F. (12-01-2018. ) A Novel Classification Proposal for Rectourethral Fistulas After Primary Treatment of Prostate Cance.European Urology Oncology, , 1 (6 ) ,510-511 More Information

Martini A.; Gupta A.; Lewis S.; Cumarasamy S.; Haines K.; Briganti A.; Montorsi F.; Tewari A. (12-01-2018. ) Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-b.BJU International, , 122 (6 ) ,1025-1033 More Information

Martini A.; Cumarasamy S.; Beksac A.T.; Abaza R.; Eun D.D.; Bhandari A.; Hemal A.K.; Porter J.R.; Badani K.K. (12-01-2018. ) A Nomogram to Predict Significant Estimated Glomerular Filtration Rate Reduction After Robotic Parti.European Urology, , 74 (6 ) ,833-839 More Information

Beksac A.T.; Cumarasamy S.; Falagario U.; Xu P.; Takhar M.; Alshalalfa M.; Gupta A.; Prasad S.; Martini A.; Thulasidass H.; Rai R.; Berger M.; Hectors S.; Jordan J.; Davicioni E.; Nair S.; Haines K.; Lewis S.; Rastinehad A.; Yadav K.; Jayaratna I.; Taouli B.; Tewari A. (12-01-2018. ) Multiparametric Magnetic Resonance Imaging Features Identify Aggressive Prostate Cancer at the Pheno.Journal of Urology, , 200 (6 ) ,1241-1249 More Information

Martini A.; Cumarasamy S.; Tewari A.K. (08-09-2018. ) MRI-targeted biopsy for prostate-cancer diagnosis.New England Journal of Medicine, , 379 (6 ) ,589 More Information

Santi R.; Martini A.; Villari D.; Nesi G. (08-01-2018. ) Ureteritis Cystica Presenting as a Single Polypoid Mass.International Journal of Surgical Pathology, , 26 (5 ) ,437-438 More Information

Badani K.K.; Reddy B.N.; Moskowitz E.J.; Paulucci D.J.; Beksac A.T.; Martini A.; Whalen M.J.; Skarecky D.W.; Huynh L.M.; Ahlering T.E. (06-01-2018. ) Lymph node yield during radical prostatectomy does not impact rate of biochemical recurrence in pati.Urologic Oncology: Seminars and Original Investigations, , 36 (6 ) ,310.e1-310.e6 More Information

Martini A.; Nicita G. (05-01-2018. ) Re: Serra-Aracil et al.: The Place of Transanal Endoscopic Surgery in the Treatment of Rectourethral.Urology, , 115 ,193-194 More Information

Moschini M.; Zamboni S.; Mattei A.; Martini A.; Zaffuto E.; Briganti A.; Gallina A.; Montorsi F. (05-01-2018. ) Evaluating the role of neoadjuvant chemotherapy in bladder cancer patients with occult lymph node me.Translational Andrology and Urology, , 7 (4 ) ,742-744 More Information

Martini A.; Cumarasamy S.; Moschini M.; Tewari A. (05-01-2018. ) The role of antibiotic prophylaxis after radical cystectomy in preventing urinary tract infections a.Translational Andrology and Urology, , 7 (4 ) ,752-753 More Information

Martini A.; Gupta A.; Cumarasamy S.; Tewari A.K. (04-01-2018. ) Re: Rita Faria, Marta O. Soares, Eldon Spackman, et al. Optimising the Diagnosis of Prostate Cancer .European Urology, , 73 (4 ) ,e108-e109 More Information

Nicita G.; Villari D.; Li Marzi V.; Milanesi M.; Saleh O.; Jaeger T.; Martini A. (03-01-2018. ) Long-term experience with a novel uterine-sparing transvaginal mesh procedure for uterovaginal prola.European Journal of Obstetrics and Gynecology and Reproductive Biology, , 222 ,57-63 More Information

Katafigiotis I.; Sfoungaristos S.; Martini A.; Stravodimos K.; Anastasiou I.; Mykoniatis I.; Duvdevani M.; Constantinides C. (10-25-2017. ) Bladder cancer to patients younger than 30 years: a retrospective study and review of the literature.Urologia, , 84 (4 ) ,231-235 More Information

Martini A.; Villari D.; Nicita G. (08-01-2017. ) Long-term complications arising from bowel interposition in the urinary tract.International Journal of Surgery, , 44 ,278-280 More Information

Martini A.; Villari D.; Nicita G. (01-01-2017. ) Editorial comment to: Ileal versus sigmoid neobladder as bladder substitute after radical cystectomy.International Journal of Surgery, , 37 ,13-14 More Information

Nicita G.; Villari D.; Caroassai Grisanti S.; Marzocco M.; Li Marzi V.; Martini A. (01-01-2017. ) Minimally Invasive Transanal Repair of Rectourethral Fistulas.European Urology, , 71 (1 ) ,133-138 More Information

Nicita G.; Martini A.; Filocamo M.; Saieva C.; Tosto A.; Stomaci N.; Bigazzi B.; Villari D. (12-01-2016. ) Use of sigmoid colon in orthotopic neobladder reconstruction: Long-term results.International Journal of Urology, , 23 (12 ) ,984-990 More Information

Nicita G.; Martini A.; Filocamo M.; Saieva C.; Tosto A.; Stomaci N.; Bigazzi B.; Villari D. (12-01-2016. ) Response to Editorial Comment to Use of sigmoid colon in orthotopic neobladder reconstruction: Long-.International Journal of Urology, , 23 (12 ) ,991 More Information

Martini A.; Dattolo E.; Raspollini M.; Villari D.; Nicita G.; Paoletti M. (11-18-2016. ) Conservative approach for a solitary fibrous tumor of the kidney.Urologia, , 83 (4 ) ,221-223 More Information

Martini A.; Dattolo E.; Frizzi J.; Villari D.; Paoletti M. (08-01-2016. ) Robotic vesico-vaginal fistula repair with no omental flap interposition.International Urogynecology Journal, , 27 (8 ) ,1277-1278 More Information

Caroassai Grisanti S.; Martini A.; Bigazzi B.; Raspollini M.; Delle Rose A.; Villari D.; Nicita G. (03-01-2016. ) Conservative Treatment of Serous Borderline Paratesticular Tumor in a Pediatric Patient.Urology, , 89 ,123-125 More Information

04-2024 Best Poster Presentation - Guidelines session. European Association of Urology meeting 2024, Paris. Level:International

01-2024 Emerging leaders in Prostate Cancer https://www.nature.com/collections/fceagcaihj/emerging-leaders Level:International

08-2023 Thought leaders of the Future. Prostate Cancer Foundation Meeting, Los Angeles, CA. Type:Recognition

07-2022 Hans Marberger Award. European Association of Urology 2022 meeting, Amsterdam, NL. Level:International

05-2022 SIU-AUA session best abstract. American Association of Urology 2022 meeting, New Orleans, LA. Level:International

10-2021 Best surgical video. Società Italiana di Urologia meeting 2021, Riccione. Level:National

03-2021 Third Prize for the Best Abstract (Oncology). European Association of Urology meeting 2021, Milan. Level:International

2020 European Urology Oncology Top 10 Reviewer Award. https://euoncology.europeanurology.com/top-ten-reviewers Level:International

07-2019 British Journal of Urology International. Article of the Week. A transcriptomic signature of tertiary Gleason 5 predicts worse clinicopathological outcome. https://www.bjuinternational.com/videos/video-transcriptomic-signature-tertiary-gleason-5-predicts-worse-clinicopathological-outcome/ Level:International

03-2019 Best Poster European Association of Urology meeting 2019, Barcelona. Best poster, Session: “Improving the oncological outcomes of cystectomy”. Level:International

12-2018 British Journal of Urology International. Article of the Week. Development and internal validation of a side‐specific, multiparametric magnetic resonance imaging‐based nomogram for the prediction of extracapsular extension of prostate cancer. https://www.bjuinternational.com/article-of-the-week/article-week-6/ Level:International

Urologic Oncology, Prostate Cancer, Robotic Prostatectomy, Robotic surgery, Kidney Cancer, Partial nephrectomy, Radical nephrectomy, Bladder Cancer, Radical cystectomy, Robot-assisted radical cystectomy,

US11903650B2 Method for providing clinical support for surgical guidance during robotic surgery Ardeshir Rastinehad, Alberto Martini, Awarded 02-2024 Inventor https://patentimages.storage.googleapis.com/32/f2/9f/1907fd009538de/US11903650.pdf

Academic - Medical Sciences Building - Room 2517
Phone: 513-558-4388
marti9a7@ucmail.uc.edu